Remsima


Vial
scheduling status
S4
registration number
52/30.1/0309
What Remsima contains
Each vial contains 100 mg Infliximab*. After reconstitution, each ml contains 10 mg Infliximab.
other ingredients
Sucrose, Sodium dihydrogen phosphate monohydrate, di-Sodium hydrogen phosphate dihydrate, Polysorbate 80.
Therapeutic classification
L04AB02 Immunosuppressants, Tumour necrosis factor alpha (TNFα).
© 2026 SAHPRA. ALL RIGHTS RESERVED